Learn how BIO Ventures for Global Health is speeding the development of new vaccines, drugs, and diagnostics for infectious diseases of poverty.
Updates on BIO Ventures for Global Health's initiatives
July 20, 2010
BIO Ventures for Global Health (BVGH) announced today that it is expanding to the West Coast with the opening of a new San Francisco headquarters office. The expansion provides BVGH the opportunity to work even more closely with the world class biotech and investor communities on both coasts. Read full press release...
May 5, 2010
The Massachusetts Institute of Technology (MIT) today became the first academic institution to contribute intellectual property to the Pool for Open Innovation against Neglected Tropical Diseases. MIT joins GlaxoSmithKline (GSK) and Alnylam Pharmaceuticals, Inc. in contributing patents to the pool, which is administered by BIO Ventures for Global Health (BVGH). The Pool for Open Innovation seeks to motivate innovative and efficient drug discovery and development by opening access to intellectual property or knowhow in neglected tropical disease research. MIT’s contribution of patents to the pool is a landmark step from one of the world’s leading research institutions toward providing access to intellectual property for use by neglected tropical disease researchers. Read full press release...
May 5, 2010
South Africa’s Technology Innovation Agency (TIA) today became the first government agency to join in the Pool for Open Innovation against Neglected Tropical Diseases. TIA intends to use intellectual property and know-how from the pool to accelerate its efforts to grow the South African biotechnology sector and enhance the quality of life of those affected by neglected tropical diseases. Initially, TIA will focus on developing new medicines for tuberculosis and malaria. Read full press release...
May 3, 2010
More than 250 global health, biopharmaceutical, academic, and donor organization leaders gathered in Chicago today (with more than 380 participating online via webcast) to share innovative ideas and best practices to speed the development of new drugs, vaccines, and diagnostics for the world’s poorest. Read full press release...
April 14, 2010
The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) announce the Partnering for Global Health Forum, an international partnering conference beginning May 3 and co-located with the BIO International Convention in Chicago, Ill. The Partnering for Global Health Forum will connect people and ideas to save lives in the developing world and focus on market-based solutions that will help speed the development of drugs, vaccines and diagnostics for the world's poorest people. The Forum will take place at the McCormick Place Lakeside Center. Read full press release ...
April 6, 2010
BIO Ventures for Global Health announced today that Donald R. Joseph, JD, has been named Chief Operating Officer (COO) and a member of the board of directors of the global health non-profit. Joseph brings to the organization a wealth of experience in the biopharmaceutical industry. Read full press release ...
January 20, 2010
BIO Ventures for Global Health, GlaxoSmithKline (GSK), and Alnylam announced today that the organizations are partnering to engage the global health community in using the powerful resources of the GSK and Alnylam Intellectual Property (IP) Pool. The IP Pool was formed in February 2009 to aid in the discovery and development of new medicines for the treatment of 16 neglected tropical diseases, as defined by the U.S. Food and Drug Administration, in the world’s least developed countries. Read full press release...
December 30, 2009
BIO Ventures for Global Health (BVGH) announced today that Melinda Moree, PhD, has been named Chief Executive Officer of the global health non-profit. Moree has served as interim CEO of BIO Ventures for Global Health since July 2009 and has been a member of the board of directors since the organization's inception in 2004. Read full press release...
September 15, 2009
BIO Ventures for Global Health (BVGH) announced today that Carl B. Feldbaum, Esq., was elected chairman of the global health non-profit’s Board of Directors. Feldbaum has served on the BVGH Board of Directors since its inception in 2004. Read full press release...
June 25, 2009
BIO Ventures for Global Health (BVGH) today announced that Christopher D. Earl, PhD, will resign from BVGH, effective July 9, 2009. Melinda Moree, PhD, a member of the board since BVGH’s inception, will serve as interim CEO until a permanent replacement is hired. Read full press release...
October 20, 2008
BIO Ventures for Global Health (BVGH) today announced its support of the US Food and Drug Administration's (FDA) release of Draft Guidance for Industry on Priority Review Vouchers. The Priority Review Voucher (PRV) program is designed to encourage industry investment in the development of drugs and vaccines for neglected tropical diseases. Read full press release...
October 14, 2008
BIO Ventures for Global Health (BVGH) today announced that the Bill & Melinda Gates Foundation has expanded its support of the organization, so it can further engage biotechnology industry innovation to create new medicines for infectious diseases of the developing world. The $7 million grant will help BVGH build the market case for biotechnology industry investment through market-based incentives and to create new opportunities for R&D collaborations. Read full press release...
February 20, 2008
The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) are pleased to announce U.S. Senator Sam Brownback, R-Kan., will deliver the Breakfast Plenary, “Incentives to Drive Innovation,” at the Partnering for Global Health Forum 2008, to be held March 11-12 near Washington, D.C. Read full press release...
January 24, 2008
The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) are pleased to announce that Anthony Fauci, MD, of NIH’s National Institute of Allergy and Infectious Diseases will be delivering a roundtable on global health from bench to bedside, and Cheryl Scott of the Bill & Melinda Gates Foundation will be delivering a fireside chat on global health issues at the Partnering for Global Health Forum, co-sponsored by the Gates Foundation. Read full press release ...
May 8 , 2007
BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) today unveiled plans to co-host the Partnering for Global Health Forum 2008. Read full press release...
February 9, 2007
BIO Ventures for Global Health (BVGH) commends today’s launch of the first Advance Market Commitment (AMC), a novel financing mechanism to encourage industry investment in much-needed vaccines for the developing world. Read full press release...
October 20, 2006
According to a groundbreaking study released today by BIO Ventures for Global Health (BVGH), a vaccine to prevent tuberculosis presents a significant opportunity for industry investment with a potential global market of US $450 million to nearly $1 billion. Read full press release...
May 24, 2006
BIO Ventures for Global Health (BVGH) announced the appointment today of Julie Klim, previously Co-Founder and Principal at Capital Royalty L.P., as Vice President of Business Development. Read full press release...
October 3, 2005
BIO Ventures for Global Health (BVGH) today announced that Christopher D. Earl, PhD, a leading venture capitalist and entrepreneur in the biotechnology industry, has been appointed president, chief executive officer and director of BVGH. Dr. Earl was previously managing director at the Perseus-Soros BioPharmaceutical Fund. Read full press release...
June 21, 2005
BIO Ventures for Global Health today announced it will expand its efforts to enlist biotechnology companies in the fight to improve global health, with a new $5.4 million grant from the Bill & Melinda Gates Foundation. The announcement was made at BIO 2005, the biotech industry’s annual convention. Read full press release...
June 7, 2004
The Biotechnology Industry Organization (BIO) today announced the launch of BIO Ventures for Global Health (BVGH), a new nonprofit organization that will work to enlist the biotechnology industry in the fight against neglected diseases. BVGH has received a $1 million start-up grant from the Bill & Melinda Gates Foundation... Read full press release...
May 3, 2004
The biotechnology industry is working to overcome hurdles to provide patients in the developing world with the significant medicines it has created to battle such devastating diseases as AIDS, malaria and tuberculosis. BIO 2004, the Biotechnology Industry Organization's (BIO's) Annual International Convention, which will take place June 6-9 at San Francisco's Moscone Center, will feature... Read full press release...